Daniel Adlerstein, Director, Atlas Genetics Ltd

Daniel has led R&D for the past 15 years developing DNA-techniques, instruments and assays for the molecular detection of infectious diseases and oncology. He joined Atlas Genetics in 2013 from Biotrin (DiaSorin Ireland), where he was the Director of Product Development & Clinical Marketing, responsible for building the molecular diagnostics programme and leading the development of the LIAISON IAM, launched in 2012